説明
Alpha-diversity metrics of the gut microbiome are compared between treatment arms at baseline and study completion.
Figure 26
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 26: Alpha-diversity metrics of the gut microbiome are compared between treatment arms at baseline and study completion.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Alpha-diversity metrics of the gut microbiome are compared between treatment arms at baseline and study completion." /> <figcaption>Figure 26. Alpha-diversity metrics of the gut microbiome are compared between treatment arms at baseline and study completion.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
関連するエビデンス
B
Bifidobacterium longum : Irritable Bowel Syndrome (IBS)
B
グレード B · 4 件の研究
Galactooligosaccharides (GOS) : Irritable Bowel Syndrome (IBS)
B
グレード B · 3 件の研究
Lactobacillus acidophilus : Irritable Bowel Syndrome (IBS)
D
グレード B · 3 件の研究
Fructooligosaccharides (FOS) : Irritable Bowel Syndrome (IBS)
グレード D · 2 件の研究